This Department of Defense (DoD) grant, the Prostate Cancer Health Disparity Research Award, supports innovative research aimed at understanding and ultimately eliminating disparities in prostate cancer incidence, morbidity, and mortality. The grant encourages studies across the spectrum from basic to clinical research, focusing on critical disparity areas such as race, ethnicity, socioeconomic status, access to healthcare, age, and cultural beliefs. While human subject research is permitted, clinical trials are excluded. The award also offers options for collaborative projects, fostering partnerships between researchers with diverse expertise, and supports new investigators in the early stages of their careers, promoting a broad approach to addressing health disparities in prostate cancer.
Opportunity ID: 89235
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-11-PCRP-HDRA |
| Funding Opportunity Title: | DoD FY11 Prostate Cancer Health Disparity Research Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 21, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jun 08, 2011 |
| Current Closing Date for Applications: | Jun 08, 2011 |
| Archive Date: | Jul 08, 2011 |
| Estimated Total Program Funding: | $3,600,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The PCRP Health Disparity Research Award mechanism was introduced in FY01. Since then, 177 applications have been received, and 45 have been recommended for funding. The Health Disparity Research Award supports new ideas for prostate cancer health disparity research with the potential to make an important contribution towards eliminating death and suffering from prostate cancer. The Health Disparity Research Award reflects the PCRP�s commitment to reduce and ultimately eliminate disparities in prostate cancer incidence, morbidity, and mortality. Studies proposed for this award mechanism are expected to improve the understanding of, and ultimately eliminate, prostate cancer health disparities. Applicants for this award must explicitly state how the proposed research is related to an area of prostate cancer health disparity. Appropriate health disparity areas include, but are not limited to, race and ethnicity, socioeconomic status, access to health care, insurance status, age, geography, and cultural beliefs. The PCRP seeks Health Disparity Research Award applications from the wide spectrum of basic to clinical research, provided they are appropriately focused on an issue of prostate cancer health disparity. In addition, all applications (1) should be relevant to at least one of the PCRP focus areas, and (2) are encouraged, although not required, to be responsive to one of the PCRP overarching challenges. Research involving human subject use is permitted under this funding opportunity, but is restricted to studies without clinical trials. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. For more information on clinical research, a Human Subject Resource Document is provided at https://cdmrp.org/Program_Announcements_and_Forms/. Principal Investigators (PIs) seeking funding for a clinical trial should consider submitting an application for the FY11 PCRP Clinical Trial Award. PIs wishing to apply for funding for population-based studies may also consider submitting an application for the FY11 PCRP Population-Based Research Award; each research project may be submitted to only one award mechanism. The Health Disparity Research Award offers two additional options for PI consideration: 1) Qualified Collaborator Option: This award mechanism strongly supports collaborative research involving basic and clinical researchers, researchers with prostate cancer expertise and those with health disparity expertise, or researchers and community organizations that may be critical to the study of populations disproportionately affected by prostate cancer. Although these and other types of collaboration are, in general, strongly encouraged, collaborations that meet specific criteria will qualify for a higher level of funding as described in Section I.D., Funding. For the application to qualify for a higher level of funding, the PI must submit a Qualified Collaboration Statement that clearly describes the collaborator and addresses how each of the criteria below are met. In addition, the collaborator must provide a letter of collaboration describing his/her involvement in the proposed work. It should be clear that the success of the project depends on the unique skills and contributions of both the PI and the qualified collaborator. The following criteria must be met to use the Qualified Collaborator Option: � The collaborator must significantly contribute to the project such that the proposed work could not be accomplished without his/her involvement. This is expected to include both intellectual input and research resources (e.g., supplies, reagents, equipment, personnel, services, tissue samples, or access to patients). � The collaborator must contribute at least a 10% level of effort to the project. Contribution of the collaborator should be reflected in the application budget. � If the PI does not have experience in prostate cancer research or working with disproportionately affected populations, the collaborator must possess such experience. 2) New Investigator Option: This award mechanism encourages applications from investigators in the early stages of their careers. The New Investigator Option is designed to allow applicants, early in their faculty appointments or in the process of developing independent research careers, to compete for funding separately from established investigators. Applications from New Investigators and Established Investigators will be peer and programmatically reviewed in separate groups. PIs using the New Investigator Option are strongly encouraged to strengthen their applications by including investigators experienced in prostate cancer research and/or possessing other relevant expertise as demonstrated by a record of funding and publications. It is the responsibility of the applicant to describe how additional investigators will augment the PI�s expertise and better address the research question. Applicants may choose to employ both the New Investigator Option and the Qualified Collaborator Option. All applicants for the New Investigator Option must meet specific eligibility criteria as described in Section I.C., Eligibility. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507
Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 89235 Full Announcement-1 -> pcrp_fy11_hdra-nio_eligibility statement.pdf
Folder 89235 Full Announcement-1 -> pcrp_fy11_hdra_ pa_gg.pdf
Packages
| Agency Contact Information: | 301-682-5507 Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00049570 | Apr 21, 2011 | Jun 08, 2011 | View |
Package 1
Mandatory forms
89235 RR_SF424_1_2-1.2.pdf
89235 PerformanceSite_1_4-1.4.pdf
89235 RR_Budget-1.1.pdf
89235 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
89235 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
